nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—CYP2B6—Ifosfamide—testicular cancer	0.129	0.22	CbGbCtD
Promethazine—CYP2C9—Ifosfamide—testicular cancer	0.0683	0.116	CbGbCtD
Promethazine—CYP2B6—Cisplatin—testicular cancer	0.0629	0.107	CbGbCtD
Promethazine—ABCB1—Dactinomycin—testicular cancer	0.0562	0.0956	CbGbCtD
Promethazine—CYP2B6—Doxorubicin—testicular cancer	0.0422	0.0718	CbGbCtD
Promethazine—ABCB1—Vinblastine—testicular cancer	0.0352	0.0599	CbGbCtD
Promethazine—CYP2C9—Cisplatin—testicular cancer	0.0332	0.0566	CbGbCtD
Promethazine—CYP2D6—Vinblastine—testicular cancer	0.0332	0.0564	CbGbCtD
Promethazine—ABCB1—Cisplatin—testicular cancer	0.0323	0.0549	CbGbCtD
Promethazine—ABCB1—Etoposide—testicular cancer	0.0317	0.054	CbGbCtD
Promethazine—ABCB1—Doxorubicin—testicular cancer	0.0216	0.0368	CbGbCtD
Promethazine—ABCB1—Methotrexate—testicular cancer	0.0209	0.0357	CbGbCtD
Promethazine—CYP2D6—Doxorubicin—testicular cancer	0.0204	0.0347	CbGbCtD
Promethazine—CALM2—semen—testicular cancer	0.0126	0.147	CbGeAlD
Promethazine—CALM1—semen—testicular cancer	0.0125	0.146	CbGeAlD
Promethazine—HTR2A—vein—testicular cancer	0.00908	0.106	CbGeAlD
Promethazine—CALM3—seminal vesicle—testicular cancer	0.00339	0.0397	CbGeAlD
Promethazine—CHRM4—testis—testicular cancer	0.00324	0.038	CbGeAlD
Promethazine—CALM2—embryo—testicular cancer	0.00283	0.0332	CbGeAlD
Promethazine—CALM1—embryo—testicular cancer	0.00282	0.0331	CbGeAlD
Promethazine—CALM2—seminal vesicle—testicular cancer	0.00266	0.0312	CbGeAlD
Promethazine—CALM3—female gonad—testicular cancer	0.00199	0.0233	CbGeAlD
Promethazine—CALM2—gonad—testicular cancer	0.00192	0.0225	CbGeAlD
Promethazine—CALM1—gonad—testicular cancer	0.00191	0.0224	CbGeAlD
Promethazine—CALM3—testis—testicular cancer	0.00177	0.0207	CbGeAlD
Promethazine—HTR2A—embryo—testicular cancer	0.00172	0.0201	CbGeAlD
Promethazine—CHRM3—female gonad—testicular cancer	0.0016	0.0187	CbGeAlD
Promethazine—CALM2—female gonad—testicular cancer	0.00156	0.0183	CbGeAlD
Promethazine—CALM1—female gonad—testicular cancer	0.00156	0.0182	CbGeAlD
Promethazine—CYP2B6—gonad—testicular cancer	0.00143	0.0168	CbGeAlD
Promethazine—CHRM3—testis—testicular cancer	0.00142	0.0166	CbGeAlD
Promethazine—CALM2—testis—testicular cancer	0.00139	0.0162	CbGeAlD
Promethazine—CALM1—testis—testicular cancer	0.00138	0.0162	CbGeAlD
Promethazine—CALM3—lymph node—testicular cancer	0.00128	0.015	CbGeAlD
Promethazine—DRD2—testis—testicular cancer	0.00127	0.0149	CbGeAlD
Promethazine—HTR2A—gonad—testicular cancer	0.00117	0.0137	CbGeAlD
Promethazine—HRH1—female gonad—testicular cancer	0.00113	0.0133	CbGeAlD
Promethazine—ABCB1—embryo—testicular cancer	0.00113	0.0132	CbGeAlD
Promethazine—ABCB1—seminal vesicle—testicular cancer	0.00106	0.0124	CbGeAlD
Promethazine—CYP2B6—testis—testicular cancer	0.00103	0.0121	CbGeAlD
Promethazine—Dyskinesia—Epirubicin—testicular cancer	0.00103	0.00339	CcSEcCtD
Promethazine—Extravasation—Doxorubicin—testicular cancer	0.00102	0.00337	CcSEcCtD
Promethazine—Decreased appetite—Chlorambucil—testicular cancer	0.00102	0.00337	CcSEcCtD
Promethazine—Tinnitus—Ifosfamide—testicular cancer	0.00102	0.00336	CcSEcCtD
Promethazine—Jaundice cholestatic—Doxorubicin—testicular cancer	0.00102	0.00335	CcSEcCtD
Promethazine—Fatigue—Chlorambucil—testicular cancer	0.00101	0.00334	CcSEcCtD
Promethazine—HRH1—testis—testicular cancer	0.00101	0.0118	CbGeAlD
Promethazine—Pain—Chlorambucil—testicular cancer	0.00101	0.00331	CcSEcCtD
Promethazine—CALM2—lymph node—testicular cancer	0.001	0.0118	CbGeAlD
Promethazine—CALM1—lymph node—testicular cancer	0.001	0.0117	CbGeAlD
Promethazine—Leukopenia—Bleomycin—testicular cancer	0.000999	0.00329	CcSEcCtD
Promethazine—Coordination abnormal—Epirubicin—testicular cancer	0.000984	0.00324	CcSEcCtD
Promethazine—Arrhythmia—Ifosfamide—testicular cancer	0.000979	0.00322	CcSEcCtD
Promethazine—Feeling abnormal—Chlorambucil—testicular cancer	0.00097	0.00319	CcSEcCtD
Promethazine—Aplastic anaemia—Methotrexate—testicular cancer	0.000969	0.00319	CcSEcCtD
Promethazine—Bradycardia—Cisplatin—testicular cancer	0.000962	0.00317	CcSEcCtD
Promethazine—Injection site reaction—Epirubicin—testicular cancer	0.00096	0.00316	CcSEcCtD
Promethazine—Dermatitis contact—Epirubicin—testicular cancer	0.000955	0.00314	CcSEcCtD
Promethazine—Erythema—Ifosfamide—testicular cancer	0.000954	0.00314	CcSEcCtD
Promethazine—Dyskinesia—Doxorubicin—testicular cancer	0.000951	0.00313	CcSEcCtD
Promethazine—Coma—Methotrexate—testicular cancer	0.000943	0.00311	CcSEcCtD
Promethazine—Jaundice—Etoposide—testicular cancer	0.00094	0.00309	CcSEcCtD
Promethazine—Decreased appetite—Vinblastine—testicular cancer	0.000938	0.00309	CcSEcCtD
Promethazine—Leukopenia—Dactinomycin—testicular cancer	0.000932	0.00307	CcSEcCtD
Promethazine—Constipation—Vinblastine—testicular cancer	0.000922	0.00304	CcSEcCtD
Promethazine—Pain—Vinblastine—testicular cancer	0.000922	0.00304	CcSEcCtD
Promethazine—Confusional state—Bleomycin—testicular cancer	0.000918	0.00302	CcSEcCtD
Promethazine—Anaphylactic shock—Bleomycin—testicular cancer	0.000911	0.003	CcSEcCtD
Promethazine—Oedema—Bleomycin—testicular cancer	0.000911	0.003	CcSEcCtD
Promethazine—Coordination abnormal—Doxorubicin—testicular cancer	0.00091	0.003	CcSEcCtD
Promethazine—Aplastic anaemia—Epirubicin—testicular cancer	0.000907	0.00299	CcSEcCtD
Promethazine—Agranulocytosis—Etoposide—testicular cancer	0.0009	0.00296	CcSEcCtD
Promethazine—Vision blurred—Ifosfamide—testicular cancer	0.000899	0.00296	CcSEcCtD
Promethazine—Thrombocytopenia—Bleomycin—testicular cancer	0.000892	0.00294	CcSEcCtD
Promethazine—Feeling abnormal—Vinblastine—testicular cancer	0.000889	0.00293	CcSEcCtD
Promethazine—Injection site reaction—Doxorubicin—testicular cancer	0.000889	0.00293	CcSEcCtD
Promethazine—Dermatitis contact—Doxorubicin—testicular cancer	0.000883	0.00291	CcSEcCtD
Promethazine—Coma—Epirubicin—testicular cancer	0.000883	0.00291	CcSEcCtD
Promethazine—Tinnitus—Cisplatin—testicular cancer	0.000881	0.0029	CcSEcCtD
Promethazine—Agitation—Ifosfamide—testicular cancer	0.000877	0.00289	CcSEcCtD
Promethazine—Thrombophlebitis—Methotrexate—testicular cancer	0.000866	0.00285	CcSEcCtD
Promethazine—CYP2D6—female gonad—testicular cancer	0.000863	0.0101	CbGeAlD
Promethazine—Leukopenia—Ifosfamide—testicular cancer	0.000854	0.00281	CcSEcCtD
Promethazine—Photosensitivity—Methotrexate—testicular cancer	0.000853	0.00281	CcSEcCtD
Promethazine—Hypotension—Bleomycin—testicular cancer	0.000851	0.0028	CcSEcCtD
Promethazine—Oedema—Dactinomycin—testicular cancer	0.00085	0.0028	CcSEcCtD
Promethazine—Asthenia—Chlorambucil—testicular cancer	0.000844	0.00278	CcSEcCtD
Promethazine—Arrhythmia—Cisplatin—testicular cancer	0.000844	0.00278	CcSEcCtD
Promethazine—Palpitations—Ifosfamide—testicular cancer	0.000843	0.00278	CcSEcCtD
Promethazine—HTR2A—testis—testicular cancer	0.000841	0.00985	CbGeAlD
Promethazine—Aplastic anaemia—Doxorubicin—testicular cancer	0.000839	0.00276	CcSEcCtD
Promethazine—Pruritus—Chlorambucil—testicular cancer	0.000833	0.00274	CcSEcCtD
Promethazine—Thrombocytopenia—Dactinomycin—testicular cancer	0.000832	0.00274	CcSEcCtD
Promethazine—Convulsion—Ifosfamide—testicular cancer	0.000826	0.00272	CcSEcCtD
Promethazine—Erythema—Cisplatin—testicular cancer	0.000822	0.00271	CcSEcCtD
Promethazine—Coma—Doxorubicin—testicular cancer	0.000817	0.00269	CcSEcCtD
Promethazine—Phlebitis—Epirubicin—testicular cancer	0.000814	0.00268	CcSEcCtD
Promethazine—Thrombophlebitis—Epirubicin—testicular cancer	0.00081	0.00267	CcSEcCtD
Promethazine—Diarrhoea—Chlorambucil—testicular cancer	0.000805	0.00265	CcSEcCtD
Promethazine—Photosensitivity—Epirubicin—testicular cancer	0.000799	0.00263	CcSEcCtD
Promethazine—Decreased appetite—Bleomycin—testicular cancer	0.000792	0.00261	CcSEcCtD
Promethazine—Muscle spasms—Cisplatin—testicular cancer	0.000791	0.0026	CcSEcCtD
Promethazine—Confusional state—Ifosfamide—testicular cancer	0.000785	0.00259	CcSEcCtD
Promethazine—Pain—Bleomycin—testicular cancer	0.000779	0.00257	CcSEcCtD
Promethazine—Anaphylactic shock—Ifosfamide—testicular cancer	0.000778	0.00256	CcSEcCtD
Promethazine—Oedema—Ifosfamide—testicular cancer	0.000778	0.00256	CcSEcCtD
Promethazine—Vision blurred—Cisplatin—testicular cancer	0.000775	0.00255	CcSEcCtD
Promethazine—Asthenia—Vinblastine—testicular cancer	0.000774	0.00255	CcSEcCtD
Promethazine—Tremor—Cisplatin—testicular cancer	0.00077	0.00254	CcSEcCtD
Promethazine—CYP2D6—testis—testicular cancer	0.000766	0.00898	CbGeAlD
Promethazine—ABCB1—gonad—testicular cancer	0.000764	0.00896	CbGeAlD
Promethazine—Thrombocytopenia—Ifosfamide—testicular cancer	0.000762	0.00251	CcSEcCtD
Promethazine—Phlebitis—Doxorubicin—testicular cancer	0.000753	0.00248	CcSEcCtD
Promethazine—Feeling abnormal—Bleomycin—testicular cancer	0.000751	0.00247	CcSEcCtD
Promethazine—Thrombophlebitis—Doxorubicin—testicular cancer	0.00075	0.00247	CcSEcCtD
Promethazine—Photosensitivity—Doxorubicin—testicular cancer	0.000739	0.00243	CcSEcCtD
Promethazine—Decreased appetite—Dactinomycin—testicular cancer	0.000738	0.00243	CcSEcCtD
Promethazine—Diarrhoea—Vinblastine—testicular cancer	0.000738	0.00243	CcSEcCtD
Promethazine—Leukopenia—Cisplatin—testicular cancer	0.000736	0.00242	CcSEcCtD
Promethazine—Fatigue—Dactinomycin—testicular cancer	0.000732	0.00241	CcSEcCtD
Promethazine—HRH1—lymph node—testicular cancer	0.00073	0.00855	CbGeAlD
Promethazine—Hypotension—Ifosfamide—testicular cancer	0.000727	0.0024	CcSEcCtD
Promethazine—Pain—Dactinomycin—testicular cancer	0.000726	0.00239	CcSEcCtD
Promethazine—Muscle spasms—Etoposide—testicular cancer	0.000724	0.00239	CcSEcCtD
Promethazine—Irritability—Methotrexate—testicular cancer	0.000715	0.00236	CcSEcCtD
Promethazine—Dizziness—Vinblastine—testicular cancer	0.000713	0.00235	CcSEcCtD
Promethazine—Convulsion—Cisplatin—testicular cancer	0.000712	0.00235	CcSEcCtD
Promethazine—Diplopia—Epirubicin—testicular cancer	0.000701	0.00231	CcSEcCtD
Promethazine—Feeling abnormal—Dactinomycin—testicular cancer	0.0007	0.00231	CcSEcCtD
Promethazine—Anxiety—Cisplatin—testicular cancer	0.000698	0.0023	CcSEcCtD
Promethazine—Somnolence—Ifosfamide—testicular cancer	0.000692	0.00228	CcSEcCtD
Promethazine—Decreased appetite—Ifosfamide—testicular cancer	0.000677	0.00223	CcSEcCtD
Promethazine—Headache—Vinblastine—testicular cancer	0.000676	0.00223	CcSEcCtD
Promethazine—Leukopenia—Etoposide—testicular cancer	0.000674	0.00222	CcSEcCtD
Promethazine—Fatigue—Ifosfamide—testicular cancer	0.000671	0.00221	CcSEcCtD
Promethazine—Oedema—Cisplatin—testicular cancer	0.000671	0.00221	CcSEcCtD
Promethazine—Anaphylactic shock—Cisplatin—testicular cancer	0.000671	0.00221	CcSEcCtD
Promethazine—Constipation—Ifosfamide—testicular cancer	0.000666	0.00219	CcSEcCtD
Promethazine—Pain—Ifosfamide—testicular cancer	0.000666	0.00219	CcSEcCtD
Promethazine—Loss of consciousness—Etoposide—testicular cancer	0.000662	0.00218	CcSEcCtD
Promethazine—Thrombocytopenia—Cisplatin—testicular cancer	0.000657	0.00216	CcSEcCtD
Promethazine—Tachycardia—Cisplatin—testicular cancer	0.000655	0.00216	CcSEcCtD
Promethazine—Asthenia—Bleomycin—testicular cancer	0.000654	0.00215	CcSEcCtD
Promethazine—Convulsion—Etoposide—testicular cancer	0.000653	0.00215	CcSEcCtD
Promethazine—Diplopia—Doxorubicin—testicular cancer	0.000649	0.00214	CcSEcCtD
Promethazine—Asthma—Methotrexate—testicular cancer	0.000648	0.00213	CcSEcCtD
Promethazine—Pruritus—Bleomycin—testicular cancer	0.000644	0.00212	CcSEcCtD
Promethazine—Feeling abnormal—Ifosfamide—testicular cancer	0.000641	0.00211	CcSEcCtD
Promethazine—Hypotension—Cisplatin—testicular cancer	0.000627	0.00207	CcSEcCtD
Promethazine—ABCB1—female gonad—testicular cancer	0.000621	0.00728	CbGeAlD
Promethazine—Confusional state—Etoposide—testicular cancer	0.00062	0.00204	CcSEcCtD
Promethazine—Anaphylactic shock—Etoposide—testicular cancer	0.000615	0.00202	CcSEcCtD
Promethazine—Asthenia—Dactinomycin—testicular cancer	0.000609	0.00201	CcSEcCtD
Promethazine—Asthma—Epirubicin—testicular cancer	0.000606	0.002	CcSEcCtD
Promethazine—Thrombocytopenia—Etoposide—testicular cancer	0.000602	0.00198	CcSEcCtD
Promethazine—Tachycardia—Etoposide—testicular cancer	0.0006	0.00198	CcSEcCtD
Promethazine—Photosensitivity reaction—Methotrexate—testicular cancer	0.000591	0.00195	CcSEcCtD
Promethazine—Decreased appetite—Cisplatin—testicular cancer	0.000583	0.00192	CcSEcCtD
Promethazine—Diarrhoea—Dactinomycin—testicular cancer	0.000581	0.00191	CcSEcCtD
Promethazine—Drowsiness—Methotrexate—testicular cancer	0.000577	0.0019	CcSEcCtD
Promethazine—Depression—Methotrexate—testicular cancer	0.000576	0.0019	CcSEcCtD
Promethazine—Hypotension—Etoposide—testicular cancer	0.000575	0.00189	CcSEcCtD
Promethazine—Rash—Bleomycin—testicular cancer	0.000574	0.00189	CcSEcCtD
Promethazine—Pain—Cisplatin—testicular cancer	0.000574	0.00189	CcSEcCtD
Promethazine—Dermatitis—Bleomycin—testicular cancer	0.000574	0.00189	CcSEcCtD
Promethazine—Asthma—Doxorubicin—testicular cancer	0.000561	0.00185	CcSEcCtD
Promethazine—Asthenia—Ifosfamide—testicular cancer	0.000559	0.00184	CcSEcCtD
Promethazine—Photosensitivity reaction—Epirubicin—testicular cancer	0.000553	0.00182	CcSEcCtD
Promethazine—Feeling abnormal—Cisplatin—testicular cancer	0.000553	0.00182	CcSEcCtD
Promethazine—ABCB1—testis—testicular cancer	0.000551	0.00646	CbGeAlD
Promethazine—Pruritus—Ifosfamide—testicular cancer	0.000551	0.00181	CcSEcCtD
Promethazine—Somnolence—Etoposide—testicular cancer	0.000547	0.0018	CcSEcCtD
Promethazine—Drowsiness—Epirubicin—testicular cancer	0.00054	0.00178	CcSEcCtD
Promethazine—Agranulocytosis—Methotrexate—testicular cancer	0.000539	0.00177	CcSEcCtD
Promethazine—Rash—Dactinomycin—testicular cancer	0.000536	0.00176	CcSEcCtD
Promethazine—Decreased appetite—Etoposide—testicular cancer	0.000534	0.00176	CcSEcCtD
Promethazine—Diarrhoea—Ifosfamide—testicular cancer	0.000533	0.00175	CcSEcCtD
Promethazine—Fatigue—Etoposide—testicular cancer	0.00053	0.00175	CcSEcCtD
Promethazine—Jaundice—Epirubicin—testicular cancer	0.000527	0.00173	CcSEcCtD
Promethazine—Pain—Etoposide—testicular cancer	0.000526	0.00173	CcSEcCtD
Promethazine—Constipation—Etoposide—testicular cancer	0.000526	0.00173	CcSEcCtD
Promethazine—Dizziness—Ifosfamide—testicular cancer	0.000515	0.0017	CcSEcCtD
Promethazine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000512	0.00169	CcSEcCtD
Promethazine—Feeling abnormal—Etoposide—testicular cancer	0.000507	0.00167	CcSEcCtD
Promethazine—Agranulocytosis—Epirubicin—testicular cancer	0.000504	0.00166	CcSEcCtD
Promethazine—Drowsiness—Doxorubicin—testicular cancer	0.0005	0.00165	CcSEcCtD
Promethazine—Bradycardia—Epirubicin—testicular cancer	0.000494	0.00163	CcSEcCtD
Promethazine—Rash—Ifosfamide—testicular cancer	0.000491	0.00162	CcSEcCtD
Promethazine—Dermatitis—Ifosfamide—testicular cancer	0.00049	0.00162	CcSEcCtD
Promethazine—Jaundice—Doxorubicin—testicular cancer	0.000487	0.00161	CcSEcCtD
Promethazine—Tinnitus—Methotrexate—testicular cancer	0.000483	0.00159	CcSEcCtD
Promethazine—Asthenia—Cisplatin—testicular cancer	0.000482	0.00159	CcSEcCtD
Promethazine—Agranulocytosis—Doxorubicin—testicular cancer	0.000467	0.00154	CcSEcCtD
Promethazine—Diarrhoea—Cisplatin—testicular cancer	0.000459	0.00151	CcSEcCtD
Promethazine—Bradycardia—Doxorubicin—testicular cancer	0.000457	0.0015	CcSEcCtD
Promethazine—Tinnitus—Epirubicin—testicular cancer	0.000452	0.00149	CcSEcCtD
Promethazine—Erythema—Methotrexate—testicular cancer	0.000451	0.00149	CcSEcCtD
Promethazine—Asthenia—Etoposide—testicular cancer	0.000441	0.00145	CcSEcCtD
Promethazine—Pruritus—Etoposide—testicular cancer	0.000435	0.00143	CcSEcCtD
Promethazine—Arrhythmia—Epirubicin—testicular cancer	0.000433	0.00143	CcSEcCtD
Promethazine—Vision blurred—Methotrexate—testicular cancer	0.000425	0.0014	CcSEcCtD
Promethazine—Rash—Cisplatin—testicular cancer	0.000423	0.00139	CcSEcCtD
Promethazine—Dermatitis—Cisplatin—testicular cancer	0.000423	0.00139	CcSEcCtD
Promethazine—Erythema—Epirubicin—testicular cancer	0.000422	0.00139	CcSEcCtD
Promethazine—Diarrhoea—Etoposide—testicular cancer	0.000421	0.00139	CcSEcCtD
Promethazine—Tinnitus—Doxorubicin—testicular cancer	0.000418	0.00138	CcSEcCtD
Promethazine—Tension—Epirubicin—testicular cancer	0.000414	0.00136	CcSEcCtD
Promethazine—Nervousness—Epirubicin—testicular cancer	0.00041	0.00135	CcSEcCtD
Promethazine—Dizziness—Etoposide—testicular cancer	0.000407	0.00134	CcSEcCtD
Promethazine—Muscle spasms—Epirubicin—testicular cancer	0.000406	0.00134	CcSEcCtD
Promethazine—Leukopenia—Methotrexate—testicular cancer	0.000404	0.00133	CcSEcCtD
Promethazine—Arrhythmia—Doxorubicin—testicular cancer	0.000401	0.00132	CcSEcCtD
Promethazine—ABCB1—lymph node—testicular cancer	0.000399	0.00468	CbGeAlD
Promethazine—Vision blurred—Epirubicin—testicular cancer	0.000398	0.00131	CcSEcCtD
Promethazine—Convulsion—Methotrexate—testicular cancer	0.000391	0.00129	CcSEcCtD
Promethazine—Erythema—Doxorubicin—testicular cancer	0.000391	0.00129	CcSEcCtD
Promethazine—Agitation—Epirubicin—testicular cancer	0.000388	0.00128	CcSEcCtD
Promethazine—Rash—Etoposide—testicular cancer	0.000388	0.00128	CcSEcCtD
Promethazine—Dermatitis—Etoposide—testicular cancer	0.000387	0.00128	CcSEcCtD
Promethazine—Headache—Etoposide—testicular cancer	0.000385	0.00127	CcSEcCtD
Promethazine—Tension—Doxorubicin—testicular cancer	0.000383	0.00126	CcSEcCtD
Promethazine—Nervousness—Doxorubicin—testicular cancer	0.000379	0.00125	CcSEcCtD
Promethazine—Syncope—Epirubicin—testicular cancer	0.000379	0.00125	CcSEcCtD
Promethazine—Leukopenia—Epirubicin—testicular cancer	0.000378	0.00124	CcSEcCtD
Promethazine—Muscle spasms—Doxorubicin—testicular cancer	0.000376	0.00124	CcSEcCtD
Promethazine—Palpitations—Epirubicin—testicular cancer	0.000373	0.00123	CcSEcCtD
Promethazine—Confusional state—Methotrexate—testicular cancer	0.000371	0.00122	CcSEcCtD
Promethazine—Loss of consciousness—Epirubicin—testicular cancer	0.000371	0.00122	CcSEcCtD
Promethazine—Anaphylactic shock—Methotrexate—testicular cancer	0.000368	0.00121	CcSEcCtD
Promethazine—Vision blurred—Doxorubicin—testicular cancer	0.000368	0.00121	CcSEcCtD
Promethazine—Convulsion—Epirubicin—testicular cancer	0.000366	0.00121	CcSEcCtD
Promethazine—Thrombocytopenia—Methotrexate—testicular cancer	0.000361	0.00119	CcSEcCtD
Promethazine—Agitation—Doxorubicin—testicular cancer	0.000359	0.00118	CcSEcCtD
Promethazine—Anxiety—Epirubicin—testicular cancer	0.000358	0.00118	CcSEcCtD
Promethazine—Dry mouth—Epirubicin—testicular cancer	0.000352	0.00116	CcSEcCtD
Promethazine—Syncope—Doxorubicin—testicular cancer	0.00035	0.00115	CcSEcCtD
Promethazine—Leukopenia—Doxorubicin—testicular cancer	0.00035	0.00115	CcSEcCtD
Promethazine—Confusional state—Epirubicin—testicular cancer	0.000348	0.00114	CcSEcCtD
Promethazine—Palpitations—Doxorubicin—testicular cancer	0.000345	0.00114	CcSEcCtD
Promethazine—Anaphylactic shock—Epirubicin—testicular cancer	0.000345	0.00114	CcSEcCtD
Promethazine—Oedema—Epirubicin—testicular cancer	0.000345	0.00114	CcSEcCtD
Promethazine—Hypotension—Methotrexate—testicular cancer	0.000344	0.00113	CcSEcCtD
Promethazine—Loss of consciousness—Doxorubicin—testicular cancer	0.000343	0.00113	CcSEcCtD
Promethazine—Shock—Epirubicin—testicular cancer	0.000339	0.00112	CcSEcCtD
Promethazine—Convulsion—Doxorubicin—testicular cancer	0.000339	0.00111	CcSEcCtD
Promethazine—Thrombocytopenia—Epirubicin—testicular cancer	0.000337	0.00111	CcSEcCtD
Promethazine—Tachycardia—Epirubicin—testicular cancer	0.000336	0.00111	CcSEcCtD
Promethazine—Insomnia—Methotrexate—testicular cancer	0.000333	0.0011	CcSEcCtD
Promethazine—Anxiety—Doxorubicin—testicular cancer	0.000332	0.00109	CcSEcCtD
Promethazine—Somnolence—Methotrexate—testicular cancer	0.000327	0.00108	CcSEcCtD
Promethazine—Dry mouth—Doxorubicin—testicular cancer	0.000325	0.00107	CcSEcCtD
Promethazine—Dyspepsia—Methotrexate—testicular cancer	0.000324	0.00107	CcSEcCtD
Promethazine—Hypotension—Epirubicin—testicular cancer	0.000322	0.00106	CcSEcCtD
Promethazine—Confusional state—Doxorubicin—testicular cancer	0.000322	0.00106	CcSEcCtD
Promethazine—Decreased appetite—Methotrexate—testicular cancer	0.00032	0.00105	CcSEcCtD
Promethazine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000319	0.00105	CcSEcCtD
Promethazine—Oedema—Doxorubicin—testicular cancer	0.000319	0.00105	CcSEcCtD
Promethazine—Fatigue—Methotrexate—testicular cancer	0.000318	0.00105	CcSEcCtD
Promethazine—Pain—Methotrexate—testicular cancer	0.000315	0.00104	CcSEcCtD
Promethazine—Shock—Doxorubicin—testicular cancer	0.000314	0.00103	CcSEcCtD
Promethazine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000312	0.00103	CcSEcCtD
Promethazine—Insomnia—Epirubicin—testicular cancer	0.000312	0.00103	CcSEcCtD
Promethazine—Tachycardia—Doxorubicin—testicular cancer	0.000311	0.00103	CcSEcCtD
Promethazine—Somnolence—Epirubicin—testicular cancer	0.000306	0.00101	CcSEcCtD
Promethazine—Feeling abnormal—Methotrexate—testicular cancer	0.000303	0.001	CcSEcCtD
Promethazine—Dyspepsia—Epirubicin—testicular cancer	0.000303	0.000999	CcSEcCtD
Promethazine—Decreased appetite—Epirubicin—testicular cancer	0.0003	0.000987	CcSEcCtD
Promethazine—Hypotension—Doxorubicin—testicular cancer	0.000298	0.000981	CcSEcCtD
Promethazine—Fatigue—Epirubicin—testicular cancer	0.000297	0.000979	CcSEcCtD
Promethazine—Pain—Epirubicin—testicular cancer	0.000295	0.000971	CcSEcCtD
Promethazine—Constipation—Epirubicin—testicular cancer	0.000295	0.000971	CcSEcCtD
Promethazine—Insomnia—Doxorubicin—testicular cancer	0.000288	0.00095	CcSEcCtD
Promethazine—Feeling abnormal—Epirubicin—testicular cancer	0.000284	0.000935	CcSEcCtD
Promethazine—Somnolence—Doxorubicin—testicular cancer	0.000283	0.000934	CcSEcCtD
Promethazine—Dyspepsia—Doxorubicin—testicular cancer	0.000281	0.000925	CcSEcCtD
Promethazine—Decreased appetite—Doxorubicin—testicular cancer	0.000277	0.000913	CcSEcCtD
Promethazine—Fatigue—Doxorubicin—testicular cancer	0.000275	0.000905	CcSEcCtD
Promethazine—Pain—Doxorubicin—testicular cancer	0.000273	0.000898	CcSEcCtD
Promethazine—Constipation—Doxorubicin—testicular cancer	0.000273	0.000898	CcSEcCtD
Promethazine—Asthenia—Methotrexate—testicular cancer	0.000264	0.00087	CcSEcCtD
Promethazine—Feeling abnormal—Doxorubicin—testicular cancer	0.000263	0.000865	CcSEcCtD
Promethazine—Pruritus—Methotrexate—testicular cancer	0.000261	0.000858	CcSEcCtD
Promethazine—Diarrhoea—Methotrexate—testicular cancer	0.000252	0.00083	CcSEcCtD
Promethazine—Asthenia—Epirubicin—testicular cancer	0.000247	0.000814	CcSEcCtD
Promethazine—Pruritus—Epirubicin—testicular cancer	0.000244	0.000803	CcSEcCtD
Promethazine—Dizziness—Methotrexate—testicular cancer	0.000244	0.000802	CcSEcCtD
Promethazine—Diarrhoea—Epirubicin—testicular cancer	0.000236	0.000777	CcSEcCtD
Promethazine—Rash—Methotrexate—testicular cancer	0.000232	0.000765	CcSEcCtD
Promethazine—Dermatitis—Methotrexate—testicular cancer	0.000232	0.000764	CcSEcCtD
Promethazine—Headache—Methotrexate—testicular cancer	0.000231	0.00076	CcSEcCtD
Promethazine—Asthenia—Doxorubicin—testicular cancer	0.000229	0.000754	CcSEcCtD
Promethazine—Dizziness—Epirubicin—testicular cancer	0.000228	0.000751	CcSEcCtD
Promethazine—Pruritus—Doxorubicin—testicular cancer	0.000226	0.000743	CcSEcCtD
Promethazine—Diarrhoea—Doxorubicin—testicular cancer	0.000218	0.000719	CcSEcCtD
Promethazine—Rash—Epirubicin—testicular cancer	0.000217	0.000716	CcSEcCtD
Promethazine—Dermatitis—Epirubicin—testicular cancer	0.000217	0.000715	CcSEcCtD
Promethazine—Headache—Epirubicin—testicular cancer	0.000216	0.000711	CcSEcCtD
Promethazine—Dizziness—Doxorubicin—testicular cancer	0.000211	0.000695	CcSEcCtD
Promethazine—Rash—Doxorubicin—testicular cancer	0.000201	0.000662	CcSEcCtD
Promethazine—Dermatitis—Doxorubicin—testicular cancer	0.000201	0.000662	CcSEcCtD
Promethazine—Headache—Doxorubicin—testicular cancer	0.0002	0.000658	CcSEcCtD
Promethazine—CALM2—Signaling by PDGF—KITLG—testicular cancer	7.97e-05	0.00337	CbGpPWpGaD
Promethazine—CALM1—Signaling by PDGF—KITLG—testicular cancer	7.97e-05	0.00337	CbGpPWpGaD
Promethazine—CALM3—B Cell Activation—KITLG—testicular cancer	7.79e-05	0.00329	CbGpPWpGaD
Promethazine—CALM1—B Cell Activation—KITLG—testicular cancer	7.54e-05	0.00319	CbGpPWpGaD
Promethazine—CALM2—B Cell Activation—KITLG—testicular cancer	7.54e-05	0.00319	CbGpPWpGaD
Promethazine—CALM3—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	7.5e-05	0.00317	CbGpPWpGaD
Promethazine—CALM3—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	7.46e-05	0.00315	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—INSL3—testicular cancer	7.43e-05	0.00314	CbGpPWpGaD
Promethazine—CALM2—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	7.26e-05	0.00307	CbGpPWpGaD
Promethazine—CALM1—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	7.26e-05	0.00307	CbGpPWpGaD
Promethazine—CALM2—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	7.21e-05	0.00305	CbGpPWpGaD
Promethazine—CALM1—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	7.21e-05	0.00305	CbGpPWpGaD
Promethazine—CALM3—Downstream signaling of activated FGFR—FGFR3—testicular cancer	7.18e-05	0.00304	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—INSL3—testicular cancer	7.12e-05	0.00301	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—INSL3—testicular cancer	7.08e-05	0.00299	CbGpPWpGaD
Promethazine—CALM3—Signaling by WNT in cancer—H2AFZ—testicular cancer	6.97e-05	0.00294	CbGpPWpGaD
Promethazine—CALM2—Downstream signaling of activated FGFR—FGFR3—testicular cancer	6.95e-05	0.00294	CbGpPWpGaD
Promethazine—CALM1—Downstream signaling of activated FGFR—FGFR3—testicular cancer	6.95e-05	0.00294	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—INSL3—testicular cancer	6.85e-05	0.0029	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—INSL3—testicular cancer	6.85e-05	0.0029	CbGpPWpGaD
Promethazine—CALM3—Downstream signal transduction—FGFR3—testicular cancer	6.75e-05	0.00285	CbGpPWpGaD
Promethazine—CALM2—Signaling by WNT in cancer—H2AFZ—testicular cancer	6.74e-05	0.00285	CbGpPWpGaD
Promethazine—CALM1—Signaling by WNT in cancer—H2AFZ—testicular cancer	6.74e-05	0.00285	CbGpPWpGaD
Promethazine—CALM3—Signaling by FGFR—FGFR3—testicular cancer	6.72e-05	0.00284	CbGpPWpGaD
Promethazine—CALM3—Signaling by ERBB2—FGFR3—testicular cancer	6.68e-05	0.00283	CbGpPWpGaD
Promethazine—CALM3—DAP12 signaling—FGFR3—testicular cancer	6.65e-05	0.00281	CbGpPWpGaD
Promethazine—CALM3—Downstream signaling of activated FGFR—KIT—testicular cancer	6.59e-05	0.00279	CbGpPWpGaD
Promethazine—CALM1—Downstream signal transduction—FGFR3—testicular cancer	6.53e-05	0.00276	CbGpPWpGaD
Promethazine—CALM2—Downstream signal transduction—FGFR3—testicular cancer	6.53e-05	0.00276	CbGpPWpGaD
Promethazine—CALM2—Signaling by FGFR—FGFR3—testicular cancer	6.5e-05	0.00275	CbGpPWpGaD
Promethazine—CALM1—Signaling by FGFR—FGFR3—testicular cancer	6.5e-05	0.00275	CbGpPWpGaD
Promethazine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	6.49e-05	0.00274	CbGpPWpGaD
Promethazine—CALM1—Signaling by ERBB2—FGFR3—testicular cancer	6.47e-05	0.00273	CbGpPWpGaD
Promethazine—CALM2—Signaling by ERBB2—FGFR3—testicular cancer	6.47e-05	0.00273	CbGpPWpGaD
Promethazine—CALM2—DAP12 signaling—FGFR3—testicular cancer	6.43e-05	0.00272	CbGpPWpGaD
Promethazine—CALM1—DAP12 signaling—FGFR3—testicular cancer	6.43e-05	0.00272	CbGpPWpGaD
Promethazine—CALM2—Downstream signaling of activated FGFR—KIT—testicular cancer	6.38e-05	0.0027	CbGpPWpGaD
Promethazine—CALM1—Downstream signaling of activated FGFR—KIT—testicular cancer	6.38e-05	0.0027	CbGpPWpGaD
Promethazine—CALM3—DAP12 interactions—FGFR3—testicular cancer	6.26e-05	0.00265	CbGpPWpGaD
Promethazine—CALM3—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	6.26e-05	0.00265	CbGpPWpGaD
Promethazine—CALM3—Signaling by FGFR in disease—FGFR3—testicular cancer	6.26e-05	0.00265	CbGpPWpGaD
Promethazine—CALM3—Signaling by EGFR—FGFR3—testicular cancer	6.2e-05	0.00262	CbGpPWpGaD
Promethazine—CALM3—Downstream signal transduction—KIT—testicular cancer	6.2e-05	0.00262	CbGpPWpGaD
Promethazine—CALM3—Signaling by FGFR—KIT—testicular cancer	6.17e-05	0.00261	CbGpPWpGaD
Promethazine—CALM3—Signaling by EGFR in Cancer—FGFR3—testicular cancer	6.15e-05	0.0026	CbGpPWpGaD
Promethazine—CALM3—Signaling by ERBB2—KIT—testicular cancer	6.14e-05	0.00259	CbGpPWpGaD
Promethazine—CALM3—Signaling by PDGF—FGFR3—testicular cancer	6.12e-05	0.00259	CbGpPWpGaD
Promethazine—CALM3—DAP12 signaling—KIT—testicular cancer	6.11e-05	0.00258	CbGpPWpGaD
Promethazine—CALM1—DAP12 interactions—FGFR3—testicular cancer	6.05e-05	0.00256	CbGpPWpGaD
Promethazine—CALM1—Signaling by FGFR in disease—FGFR3—testicular cancer	6.05e-05	0.00256	CbGpPWpGaD
Promethazine—CALM2—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	6.05e-05	0.00256	CbGpPWpGaD
Promethazine—CALM1—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	6.05e-05	0.00256	CbGpPWpGaD
Promethazine—CALM2—DAP12 interactions—FGFR3—testicular cancer	6.05e-05	0.00256	CbGpPWpGaD
Promethazine—CALM2—Signaling by FGFR in disease—FGFR3—testicular cancer	6.05e-05	0.00256	CbGpPWpGaD
Promethazine—CALM1—Signaling by EGFR—FGFR3—testicular cancer	6e-05	0.00254	CbGpPWpGaD
Promethazine—CALM2—Signaling by EGFR—FGFR3—testicular cancer	6e-05	0.00254	CbGpPWpGaD
Promethazine—CALM2—Downstream signal transduction—KIT—testicular cancer	6e-05	0.00253	CbGpPWpGaD
Promethazine—CALM1—Downstream signal transduction—KIT—testicular cancer	6e-05	0.00253	CbGpPWpGaD
Promethazine—CALM1—Signaling by FGFR—KIT—testicular cancer	5.97e-05	0.00252	CbGpPWpGaD
Promethazine—CALM2—Signaling by FGFR—KIT—testicular cancer	5.97e-05	0.00252	CbGpPWpGaD
Promethazine—CALM1—Signaling by EGFR in Cancer—FGFR3—testicular cancer	5.95e-05	0.00251	CbGpPWpGaD
Promethazine—CALM2—Signaling by EGFR in Cancer—FGFR3—testicular cancer	5.95e-05	0.00251	CbGpPWpGaD
Promethazine—CALM2—Signaling by ERBB2—KIT—testicular cancer	5.94e-05	0.00251	CbGpPWpGaD
Promethazine—CALM1—Signaling by ERBB2—KIT—testicular cancer	5.94e-05	0.00251	CbGpPWpGaD
Promethazine—CALM1—Signaling by PDGF—FGFR3—testicular cancer	5.92e-05	0.0025	CbGpPWpGaD
Promethazine—CALM2—Signaling by PDGF—FGFR3—testicular cancer	5.92e-05	0.0025	CbGpPWpGaD
Promethazine—CALM1—DAP12 signaling—KIT—testicular cancer	5.91e-05	0.0025	CbGpPWpGaD
Promethazine—CALM2—DAP12 signaling—KIT—testicular cancer	5.91e-05	0.0025	CbGpPWpGaD
Promethazine—CALM3—B Cell Activation—FGFR3—testicular cancer	5.79e-05	0.00245	CbGpPWpGaD
Promethazine—CALM3—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	5.75e-05	0.00243	CbGpPWpGaD
Promethazine—CALM3—DAP12 interactions—KIT—testicular cancer	5.75e-05	0.00243	CbGpPWpGaD
Promethazine—CALM3—Signaling by FGFR in disease—KIT—testicular cancer	5.75e-05	0.00243	CbGpPWpGaD
Promethazine—CALM3—Signaling by Wnt—H2AFZ—testicular cancer	5.74e-05	0.00243	CbGpPWpGaD
Promethazine—CALM3—Signaling by NGF—KITLG—testicular cancer	5.74e-05	0.00242	CbGpPWpGaD
Promethazine—CALM3—Signaling by EGFR—KIT—testicular cancer	5.69e-05	0.00241	CbGpPWpGaD
Promethazine—CALM3—Signaling by EGFR in Cancer—KIT—testicular cancer	5.64e-05	0.00239	CbGpPWpGaD
Promethazine—CALM3—Signaling by PDGF—KIT—testicular cancer	5.62e-05	0.00237	CbGpPWpGaD
Promethazine—CALM1—B Cell Activation—FGFR3—testicular cancer	5.6e-05	0.00237	CbGpPWpGaD
Promethazine—CALM2—B Cell Activation—FGFR3—testicular cancer	5.6e-05	0.00237	CbGpPWpGaD
Promethazine—CALM1—Signaling by FGFR in disease—KIT—testicular cancer	5.56e-05	0.00235	CbGpPWpGaD
Promethazine—CALM2—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	5.56e-05	0.00235	CbGpPWpGaD
Promethazine—CALM2—DAP12 interactions—KIT—testicular cancer	5.56e-05	0.00235	CbGpPWpGaD
Promethazine—CALM2—Signaling by FGFR in disease—KIT—testicular cancer	5.56e-05	0.00235	CbGpPWpGaD
Promethazine—CALM1—DAP12 interactions—KIT—testicular cancer	5.56e-05	0.00235	CbGpPWpGaD
Promethazine—CALM1—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	5.56e-05	0.00235	CbGpPWpGaD
Promethazine—CALM1—Signaling by Wnt—H2AFZ—testicular cancer	5.55e-05	0.00235	CbGpPWpGaD
Promethazine—CALM2—Signaling by Wnt—H2AFZ—testicular cancer	5.55e-05	0.00235	CbGpPWpGaD
Promethazine—CALM1—Signaling by NGF—KITLG—testicular cancer	5.55e-05	0.00235	CbGpPWpGaD
Promethazine—CALM2—Signaling by NGF—KITLG—testicular cancer	5.55e-05	0.00235	CbGpPWpGaD
Promethazine—CALM3—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	5.54e-05	0.00234	CbGpPWpGaD
Promethazine—CALM2—Signaling by EGFR—KIT—testicular cancer	5.51e-05	0.00233	CbGpPWpGaD
Promethazine—CALM1—Signaling by EGFR—KIT—testicular cancer	5.51e-05	0.00233	CbGpPWpGaD
Promethazine—CALM2—Signaling by EGFR in Cancer—KIT—testicular cancer	5.46e-05	0.00231	CbGpPWpGaD
Promethazine—CALM1—Signaling by EGFR in Cancer—KIT—testicular cancer	5.46e-05	0.00231	CbGpPWpGaD
Promethazine—CALM2—Signaling by PDGF—KIT—testicular cancer	5.43e-05	0.0023	CbGpPWpGaD
Promethazine—CALM1—Signaling by PDGF—KIT—testicular cancer	5.43e-05	0.0023	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—BCL10—testicular cancer	5.43e-05	0.00229	CbGpPWpGaD
Promethazine—CALM1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	5.36e-05	0.00227	CbGpPWpGaD
Promethazine—CALM2—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	5.36e-05	0.00227	CbGpPWpGaD
Promethazine—CALM3—B Cell Activation—KIT—testicular cancer	5.32e-05	0.00225	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—BCL10—testicular cancer	5.25e-05	0.00222	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—BCL10—testicular cancer	5.25e-05	0.00222	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—BCL10—testicular cancer	5.21e-05	0.0022	CbGpPWpGaD
Promethazine—CALM2—B Cell Activation—KIT—testicular cancer	5.14e-05	0.00217	CbGpPWpGaD
Promethazine—CALM1—B Cell Activation—KIT—testicular cancer	5.14e-05	0.00217	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—INSL3—testicular cancer	5.12e-05	0.00216	CbGpPWpGaD
Promethazine—CALM3—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	5.09e-05	0.00215	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—BCL10—testicular cancer	5.04e-05	0.00213	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—BCL10—testicular cancer	5.04e-05	0.00213	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—INSL3—testicular cancer	5.04e-05	0.00213	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—INSL3—testicular cancer	5.03e-05	0.00213	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—INSL3—testicular cancer	5.01e-05	0.00212	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—INSL3—testicular cancer	5e-05	0.00211	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—INSL3—testicular cancer	4.95e-05	0.00209	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—INSL3—testicular cancer	4.93e-05	0.00209	CbGpPWpGaD
Promethazine—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	4.92e-05	0.00208	CbGpPWpGaD
Promethazine—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	4.92e-05	0.00208	CbGpPWpGaD
Promethazine—CALM3—Signaling by NGF—FGFR3—testicular cancer	4.26e-05	0.0018	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—H2AFZ—testicular cancer	4.24e-05	0.00179	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—STK11—testicular cancer	4.22e-05	0.00178	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—INSL3—testicular cancer	4.18e-05	0.00177	CbGpPWpGaD
Promethazine—CALM2—Signaling by NGF—FGFR3—testicular cancer	4.12e-05	0.00174	CbGpPWpGaD
Promethazine—CALM1—Signaling by NGF—FGFR3—testicular cancer	4.12e-05	0.00174	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—INSL3—testicular cancer	4.05e-05	0.00171	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—INSL3—testicular cancer	4.05e-05	0.00171	CbGpPWpGaD
Promethazine—CALM3—Signaling by NGF—KIT—testicular cancer	3.91e-05	0.00165	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—KITLG—testicular cancer	3.9e-05	0.00165	CbGpPWpGaD
Promethazine—CALM1—Signaling by NGF—KIT—testicular cancer	3.79e-05	0.0016	CbGpPWpGaD
Promethazine—CALM2—Signaling by NGF—KIT—testicular cancer	3.79e-05	0.0016	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.48e-05	0.00147	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—KITLG—testicular cancer	3.27e-05	0.00138	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—KITLG—testicular cancer	3.16e-05	0.00134	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—KITLG—testicular cancer	3.16e-05	0.00134	CbGpPWpGaD
Promethazine—CALM3—Immune System—BCL10—testicular cancer	3.16e-05	0.00134	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—KITLG—testicular cancer	3.14e-05	0.00133	CbGpPWpGaD
Promethazine—CALM2—Immune System—BCL10—testicular cancer	3.06e-05	0.00129	CbGpPWpGaD
Promethazine—CALM1—Immune System—BCL10—testicular cancer	3.06e-05	0.00129	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—KITLG—testicular cancer	3.04e-05	0.00128	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—KITLG—testicular cancer	3.04e-05	0.00128	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—FGFR3—testicular cancer	2.9e-05	0.00123	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—KIT—testicular cancer	2.66e-05	0.00113	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—HPGDS—testicular cancer	2.62e-05	0.00111	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—FGFR3—testicular cancer	2.43e-05	0.00103	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—H2AFZ—testicular cancer	2.38e-05	0.00101	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—STK11—testicular cancer	2.37e-05	0.001	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—FGFR3—testicular cancer	2.35e-05	0.000994	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—FGFR3—testicular cancer	2.35e-05	0.000994	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—FGFR3—testicular cancer	2.33e-05	0.000987	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—H2AFZ—testicular cancer	2.28e-05	0.000963	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—STK11—testicular cancer	2.27e-05	0.000958	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—FGFR3—testicular cancer	2.26e-05	0.000955	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—FGFR3—testicular cancer	2.26e-05	0.000955	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—HPGDS—testicular cancer	2.25e-05	0.000952	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—KIT—testicular cancer	2.23e-05	0.000944	CbGpPWpGaD
Promethazine—CALM3—Metabolism—HPGDS—testicular cancer	2.19e-05	0.000926	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—KITLG—testicular cancer	2.19e-05	0.000925	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—KIT—testicular cancer	2.16e-05	0.000913	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—KIT—testicular cancer	2.16e-05	0.000913	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—KIT—testicular cancer	2.14e-05	0.000906	CbGpPWpGaD
Promethazine—CALM1—Metabolism—HPGDS—testicular cancer	2.12e-05	0.000896	CbGpPWpGaD
Promethazine—CALM2—Metabolism—HPGDS—testicular cancer	2.12e-05	0.000896	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—KITLG—testicular cancer	2.1e-05	0.000886	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—KIT—testicular cancer	2.07e-05	0.000876	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—KIT—testicular cancer	2.07e-05	0.000876	CbGpPWpGaD
Promethazine—CALM3—Disease—H2AFZ—testicular cancer	1.91e-05	0.000808	CbGpPWpGaD
Promethazine—CALM3—Immune System—KITLG—testicular cancer	1.91e-05	0.000805	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—STK11—testicular cancer	1.9e-05	0.000804	CbGpPWpGaD
Promethazine—CALM1—Disease—H2AFZ—testicular cancer	1.85e-05	0.000782	CbGpPWpGaD
Promethazine—CALM2—Disease—H2AFZ—testicular cancer	1.85e-05	0.000782	CbGpPWpGaD
Promethazine—CALM1—Immune System—KITLG—testicular cancer	1.84e-05	0.000779	CbGpPWpGaD
Promethazine—CALM2—Immune System—KITLG—testicular cancer	1.84e-05	0.000779	CbGpPWpGaD
Promethazine—CALM3—Disease—KITLG—testicular cancer	1.76e-05	0.000744	CbGpPWpGaD
Promethazine—CALM1—Disease—KITLG—testicular cancer	1.7e-05	0.000719	CbGpPWpGaD
Promethazine—CALM2—Disease—KITLG—testicular cancer	1.7e-05	0.000719	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—HPGDS—testicular cancer	1.66e-05	0.000702	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—H2AFZ—testicular cancer	1.64e-05	0.000693	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—STK11—testicular cancer	1.64e-05	0.000692	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—STK11—testicular cancer	1.63e-05	0.000689	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—FGFR3—testicular cancer	1.63e-05	0.000688	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—H2AFZ—testicular cancer	1.61e-05	0.000682	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—H2AFZ—testicular cancer	1.61e-05	0.00068	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—H2AFZ—testicular cancer	1.6e-05	0.000678	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—STK11—testicular cancer	1.6e-05	0.000678	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—STK11—testicular cancer	1.6e-05	0.000676	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—H2AFZ—testicular cancer	1.6e-05	0.000676	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—STK11—testicular cancer	1.6e-05	0.000674	CbGpPWpGaD
Promethazine—CALM3—Metabolism—STK11—testicular cancer	1.59e-05	0.000673	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—STK11—testicular cancer	1.59e-05	0.000672	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—H2AFZ—testicular cancer	1.58e-05	0.000669	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—H2AFZ—testicular cancer	1.58e-05	0.000668	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—STK11—testicular cancer	1.57e-05	0.000666	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—STK11—testicular cancer	1.57e-05	0.000664	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—HPGDS—testicular cancer	1.56e-05	0.000662	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—FGFR3—testicular cancer	1.56e-05	0.000659	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—HPGDS—testicular cancer	1.55e-05	0.000656	CbGpPWpGaD
Promethazine—CALM2—Metabolism—STK11—testicular cancer	1.54e-05	0.000651	CbGpPWpGaD
Promethazine—CALM1—Metabolism—STK11—testicular cancer	1.54e-05	0.000651	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—KITLG—testicular cancer	1.51e-05	0.000638	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—KIT—testicular cancer	1.49e-05	0.000631	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—KITLG—testicular cancer	1.48e-05	0.000627	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—KITLG—testicular cancer	1.48e-05	0.000626	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—KITLG—testicular cancer	1.48e-05	0.000624	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—KITLG—testicular cancer	1.47e-05	0.000622	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—KITLG—testicular cancer	1.46e-05	0.000616	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—KITLG—testicular cancer	1.45e-05	0.000614	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—KIT—testicular cancer	1.43e-05	0.000605	CbGpPWpGaD
Promethazine—CALM3—Immune System—FGFR3—testicular cancer	1.42e-05	0.000599	CbGpPWpGaD
Promethazine—CALM2—Immune System—FGFR3—testicular cancer	1.37e-05	0.000579	CbGpPWpGaD
Promethazine—CALM1—Immune System—FGFR3—testicular cancer	1.37e-05	0.000579	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—H2AFZ—testicular cancer	1.34e-05	0.000566	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—STK11—testicular cancer	1.33e-05	0.000563	CbGpPWpGaD
Promethazine—CALM3—Disease—FGFR3—testicular cancer	1.31e-05	0.000553	CbGpPWpGaD
Promethazine—CALM3—Immune System—KIT—testicular cancer	1.3e-05	0.00055	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—H2AFZ—testicular cancer	1.3e-05	0.000548	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—H2AFZ—testicular cancer	1.3e-05	0.000548	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—STK11—testicular cancer	1.29e-05	0.000544	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—STK11—testicular cancer	1.29e-05	0.000544	CbGpPWpGaD
Promethazine—CALM2—Disease—FGFR3—testicular cancer	1.26e-05	0.000535	CbGpPWpGaD
Promethazine—CALM1—Disease—FGFR3—testicular cancer	1.26e-05	0.000535	CbGpPWpGaD
Promethazine—CALM1—Immune System—KIT—testicular cancer	1.26e-05	0.000532	CbGpPWpGaD
Promethazine—CALM2—Immune System—KIT—testicular cancer	1.26e-05	0.000532	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KITLG—testicular cancer	1.23e-05	0.000521	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—STK11—testicular cancer	1.21e-05	0.00051	CbGpPWpGaD
Promethazine—CALM3—Disease—KIT—testicular cancer	1.2e-05	0.000507	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KITLG—testicular cancer	1.19e-05	0.000504	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KITLG—testicular cancer	1.19e-05	0.000504	CbGpPWpGaD
Promethazine—CALM1—Disease—KIT—testicular cancer	1.16e-05	0.000491	CbGpPWpGaD
Promethazine—CALM2—Disease—KIT—testicular cancer	1.16e-05	0.000491	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—STK11—testicular cancer	1.14e-05	0.000481	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—STK11—testicular cancer	1.13e-05	0.000476	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—FGFR3—testicular cancer	1.12e-05	0.000474	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—FGFR3—testicular cancer	1.1e-05	0.000466	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—FGFR3—testicular cancer	1.1e-05	0.000465	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—FGFR3—testicular cancer	1.1e-05	0.000464	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—FGFR3—testicular cancer	1.09e-05	0.000462	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—FGFR3—testicular cancer	1.08e-05	0.000458	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—FGFR3—testicular cancer	1.08e-05	0.000456	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—KIT—testicular cancer	1.03e-05	0.000435	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—KIT—testicular cancer	1.01e-05	0.000428	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—KIT—testicular cancer	1.01e-05	0.000427	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—KIT—testicular cancer	1.01e-05	0.000426	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—KIT—testicular cancer	1e-05	0.000424	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—KIT—testicular cancer	9.94e-06	0.00042	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—KIT—testicular cancer	9.92e-06	0.000419	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—FGFR3—testicular cancer	9.16e-06	0.000387	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—FGFR3—testicular cancer	8.86e-06	0.000374	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—FGFR3—testicular cancer	8.86e-06	0.000374	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KIT—testicular cancer	8.41e-06	0.000355	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KIT—testicular cancer	8.13e-06	0.000344	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KIT—testicular cancer	8.13e-06	0.000344	CbGpPWpGaD
